Delivery Order SPM2DX12D0001-A150
- Not listed
- The U.S. government's Defense Logistics Agency (DLA) awarded a firm fixed-price Delivery Order contract worth $3,543.88 to Cardinal Health, Inc. for pharmaceutical prime vendor fleet services. This contract is part of the DLA's Pharmaceutical Prime Vendor program, which supplies a comprehensive range of medical products to military treatment facilities and deployed troops worldwide. Cardinal Health, a global healthcare services and products company, will provide a variety of pharmaceutical and...
- This is a federal contract award to Cardinal Health, Inc., a global healthcare services and products company, by the Defense Logistics Agency (DLA) for pharmaceutical prime vendor services. The contract, valued at $269,379.12, is a firm fixed-price delivery order under the DLA's Pharmaceutical Prime Vendor program, which supplies a comprehensive range of medical products to military treatment facilities and deployed troops worldwide. The contract has no set-aside designation, reflecting Cardinal...
- This is a federal contract award to Cardinal Health, Inc., a major healthcare services and products company, by the Defense Logistics Agency (DLA) for pharmaceutical prime vendor services. The contract, with a ceiling value of $1,476.39, is a delivery order under the DLA's Pharmaceutical Prime Vendor program, which supplies a comprehensive range of medical products to military treatment facilities and deployed troops worldwide. The contract has no set-aside designation, indicating Cardinal...
- This is a federal contract award to Cardinal Health, Inc., a global healthcare services and products company, by the Defense Logistics Agency (DLA) for pharmaceutical prime vendor services. The single-award contract, valued at $1,530.96, is a firm fixed-price delivery order under the DLA's Pharmaceutical Prime Vendor program. This program provides a comprehensive range of medical products, including prescription medications, vaccines, and specialty drugs, to military treatment facilities and...
- This is a federal contract awarded by the Defense Logistics Agency (DLA) to Cardinal Health, Inc. for pharmaceutical prime vendor services. The contract has a ceiling value of $2,598.94 and a completion date of September 16, 2024. It is a firm fixed-price delivery order contract, with no set-aside designation. Cardinal Health, a global healthcare services and products company, has a long-standing relationship with the U.S. federal government, providing pharmaceutical distribution and specialized...
- This federal contract award is a delivery order, SPE2DX24F0P46, with a ceiling value of $6,904.48, issued by the Defense Logistics Agency (DLA) to Cardinal Health, Inc. for the Pharmaceutical Prime Vendor Fleet program. Cardinal Health, a global healthcare services and products company, will provide pharmaceutical distribution services, including prescription medications, over-the-counter drugs, vaccines, and other medical consumables, to military treatment facilities and deployed troops...
- The Department of Defense's Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to Cardinal Health, Inc. to provide pharmaceutical prime vendor fleet services. The contract, valued at $1,135.68, has an ultimate completion date of August 15, 2024. As a major supplier of pharmaceutical and medical products to the federal government, Cardinal Health leverages its extensive distribution network to deliver a wide range of medications, including antibiotics, pain...
- This federal contract award is for a Pharmaceutical Prime Vendor fleet, awarded by the Defense Logistics Agency (DLA) to Cardinal Health, Inc. The contract has a ceiling value of $1,729.13 and is a Firm Fixed Price Delivery Order with a period of performance through July 23, 2024. Cardinal Health, a major healthcare services and products company, will provide a comprehensive range of pharmaceutical and medical supplies, including prescription medications, over-the-counter drugs, vaccines, and...
- This federal contract award is for a Pharmaceutical Prime Vendor Fleet delivery order (SPE2DX22F0W63) with a ceiling value of $1,092.38. It was awarded by the Defense Logistics Agency (DLA) to Cardinal Health, Inc., a global healthcare services and products company. The contract is a firm fixed-price delivery order under the DLA's Pharmaceutical Prime Vendor program, which provides prescription medications, over-the-counter drugs, vaccines, and other medical consumables to military treatment...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Cardinal Health, Inc., a global healthcare services and products company. The contract, with a ceiling value of $1,521.80, is for pharmaceutical prime vendor services to supply a comprehensive range of medical products, including prescription medications, over-the-counter drugs, vaccines, and other medical consumables, to military treatment facilities and deployed troops worldwide. The contract is a delivery order...
- SPM2DX12D0001Indefinite Delivery Contract
- SPM2DX12D0001-A150Delivery Order
This is a federal contract award to Cardinal Health, Inc., a global healthcare services and products company, by the Defense Logistics Agency (DLA) for pharmaceutical prime vendor fleet services. The contract has a ceiling value of $111,868.11 and is a firm fixed-price delivery order with no set-aside designation. The contract is part of the DLA's Pharmaceutical Prime Vendor program, which supplies a comprehensive range of medical products to military treatment facilities and deployed troops worldwide. Cardinal Health has a long-standing relationship with the federal government, having been registered to receive awards since June 2001. In addition to this contract, Cardinal Health holds a significant indefinite delivery contract with the Department of Veterans Affairs (VA) for the provision of radiopharmaceutical products to support medical imaging procedures within the VA healthcare system, as well as a single-award indefinite delivery contract with the VA National Acquisition Center for the supply of Lurasidone Hydrochloride tablets.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $111.9k | 5/7/15 |